Top Markets
Coin of the day
Enveric Biosciences, Inc. Enveric Biosciences, Inc.

Enveric Biosciences, Inc.

ENVB
Peringkat dalam Saham #38625
Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse... Enveric Biosciences, Inc. is a pharmaceutical firm focused on advancing diverse cannabinoid-based medications, primarily for use in cancer care. The company's robust product pipeline includes EV104, developed for treating osteoarthritis, and EVM-101 and EVM-201, which are intended to alleviate cancer-related distress. Furthermore, EVM-301 is under development for a mental health indication, alongside EV102, a cannabinoid cream formulated for topical skin application. Rounding out their portfolio is EV101, a novel combination therapy integrating cannabinoids with chemotherapy. This innovative company is based in Naples, Florida.
Harga Saham
$1.52
Kapitalisasi Pasar
$907.46K
Perubahan (1 hari)
0.66%
Perubahan (1 tahun)
-88.59%
Negara
US
Perdagangan Enveric Biosciences, Inc. (ENVB)

Kategori

Harga ENVB dengan kapitalisasi pasar B
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
ENVB
$1.52
Kapitalisasi pasar dari Enveric Biosciences, Inc.(ENVB)
Kapitalisasi Pasar: $907.46K
Per August 2026, Enveric Biosciences, Inc. memiliki kapitalisasi pasar sebesar $907.46K. Ini menjadikan Enveric Biosciences, Inc. sebagai perusahaan 38625th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Enveric Biosciences, Inc. dari 2005 hingga 2026
ENVB dibandingkan dengan 5 teratas stocks paling populer
Harga ENVB Aset B Pasar B Hasil
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$9,134,273 $907.46K
$5.453T +600,938,892.00%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$7,514,179 $907.46K
$4.486T +494,353,753.84%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$6,966,733 $907.46K
$4.159T +458,337,625.28%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$6,182,869 $907.46K
$3.691T +406,767,608.44%
Enveric Biosciences, Inc. Enveric Biosciences, Inc.
$4,762,066 $907.46K
$2.843T +313,293,716.57%